The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth
jetcityimage / iStock Editorial via Getty Images Lilly posted 53.9% revenue growth and 480% net income growth driven…
Amazon Adds Novo Nordisk’s Wegovy Pill to Pharmacy Platform
This article first appeared on GuruFocus. Amazon Pharmacy (AMZN, Financials) stated that it is now selling Novo Nordisk’s…
New Wegovy pill offers weight loss alternative to injections
WILMINGTON, N.C. (WECT) – A new weight loss option is now available for people seeking alternatives to weekly…
Companies can make generic Ozempic as of next week, but don’t expect to get it soon
TORONTO — Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug…
Where Will Pfizer Be in 5 Years?
Pfizer’s stock soared during the coronavirus pandemic because of its COVID-19 vaccine. The world has learned to live…
GLP-1 Drugs Quietly Reshape How Americans Shop for Food, Study Finds
This article first appeared on GuruFocus. Weight loss may be just one side effect of GLP-1 drugs. A…
Novo’s Wegovy pill to test demand from consumers with cash
LONDON, Dec 23 (Reuters) – Novo Nordisk’s newly approved weight-loss pill version of Wegovy will be a test…
Popular weightloss drug Ozempic launched in India at the price of Rs…, check dosage, more details
Danish drugmaker Novo Nordisk launched its most popular weight-loss drug Ozempic in India on Friday. The price of…
Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments
How do you swear in Danish? Our AI chatbots are much too polite to help us out here,…
Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
By Deena Beasley Dec 12 (Reuters) – Alzheimer’s trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their…
High-Dose Wegovy Takes Aim at Lilly’s Zepbound
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) said its high-dose version of Wegovy has received a…
Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer’s trials
By Deena Beasley SAN DIEGO Dec 2 (Reuters) – Novo Nordisk in 2020 launched pivotal trials of its…